P. Yeung

发表

A randomized, placebo-controlled repeat-dose thorough QT study of inhaled loxapine in healthy volunteers.

D. Spyker, J. Cassella, P. Yeung, 2015, International journal of clinical pharmacology and therapeutics.

A randomized, placebo-controlled repeat-dose thorough QT study of inhaled loxapine in healthy volunteers

D. Spyker, J. Cassella, P. Yeung, 2015, International journal of clinical pharmacology and therapeutics.

Long-term safety, tolerability, and efficacy of fremanezumab in migraine

S. Silberstein, D. Dodick, P. Goadsby, 2020, Neurology.

Inhaled loxapine and intramuscular lorazepam in healthy volunteers: a randomized placebo‐controlled drug–drug interaction study

D. Spyker, J. Cassella, P. Yeung, 2015, Pharmacology research & perspectives.

Fremanezumab for the Preventive Treatment of Chronic Migraine

S. Silberstein, D. Dodick, P. Goadsby, 2017, The New England journal of medicine.

Quetiapine for Elderly Patients With Psychotic Disorders

L. Schneider, P. Tariot, C. Salzman, 2000 .

Long-Term, Open-Label Venlafaxine Extended-Release Treatment in Children and Adolescents with Major Depressive Disorder

G. Emslie, P. Yeung, N. Kunz, 2007, CNS Spectrums.

Clinical Improvement and tolerability is maintained long term in elderly patients with psychotic disorders treated with quetiapine

P. Tariot, C. Salzman, P. Yeung, 1999, European Neuropsychopharmacology.

QUETIAPINE IMPROVES PSYCHOTIC SYMPTOMS ASSOCIATED WITH PARKISON's DISEASE

C. Nemeroff, J. Juncos, P. Yeung, 1999 .

Pharmacokinetics, Safety, and Tolerability of Cariprazine in Pediatric Patients with Bipolar I Disorder or Schizophrenia.

T. Riccobene, A. Hankinson, W. Earley, 2022, Journal of child and adolescent psychopharmacology.

Effects of fremanezumab on the use of acute headache medication and associated symptoms of migraine in patients with episodic migraine

E. Aycardi, Ronghua Yang, Yuju Ma, 2019, Cephalalgia : an international journal of headache.

Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine

P. Winner, E. Aycardi, Ronghua Yang, 2019, Headache.

A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects

P. Loupe, E. Aycardi, O. Spiegelstein, 2018, Cephalalgia : an international journal of headache.

Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial

S. Silberstein, D. Dodick, P. Goadsby, 2018, JAMA.

11th European Headache Federation Congress jointly with 31st Congress of the Italian Society for the Study of Headaches

E. Aycardi, O. Cohen‐Barak, P. Yeung, 2017, The Journal of Headache and Pain.

Burden of Alcohol Abuse or Dependence Among Long-Term Opioid Users with Chronic Noncancer Pain.

Nathaniel Katz, Richard White, K. Gajria, 2017, Journal of managed care & specialty pharmacy.

Safety and Tolerability of Fremanezumab for the Prevention of Migraine: A Pooled Analysis of Phases 2b and 3 Clinical Trials

S. Silberstein, E. Aycardi, Ronghua Yang, 2019, Headache.

Jewish Americans and mental health: results of the NIMH Epidemiologic Catchment Area Study

S. Greenwald, P. Yeung, 1992, Social Psychiatry and Psychiatric Epidemiology.

Risperidone in Adults with Autism or Pervasive Developmental Disorder

C. McDougle, D. Cohen, L. Price, 1995 .

Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials.

Robert L Findling, R. Findling, G. Emslie, 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

Long-Term use of quetiapine in elderly patients with psychotic disorders.

P. Tariot, C. Salzman, P. Yeung, 2000, Clinical therapeutics.

A double-blind, placebo-controlled study of the efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder.

N. DeMartinis, P. Yeung, R. Entsuah, 2007, The Journal of clinical psychiatry.

Effect of fremanezumab on quality of life and productivity in patients with chronic migraine

R. Lipton, Ronghua Yang, D. Buse, 2020, Neurology.

Fremanezumab for the preventive treatment of migraine

S. Silberstein, Joshua M. Cohen, P. Yeung, 2019, Expert opinion on biological therapy.

Response to inhaled loxapine in patients with schizophrenia or bipolar I disorder: PANSS-EC responder analyses

D. Spyker, L. Zun, S. Zeller, 2017, BJPsych Open.

Quetiapine improves psychotic symptoms and cognition in Parkinson's disease

L. S. Potter, V. J. Roberts, M. Evatt, 2004, Movement disorders : official journal of the Movement Disorder Society.

A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in adult outpatients with major depressive disorder.

M. Liebowitz, P. Yeung, R. Entsuah, 2007, The Journal of clinical psychiatry.

Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials.

M. Riddle, M. Rynn, Mark A Riddle, 2007, The American journal of psychiatry.

Safety and Tolerability of Cariprazine for the Adjunctive Treatment of Major Depressive Disorder: A Pooled Analysis of Phase 2B and 3 Clinical Trials

M. Thase, A. Hankinson, W. Earley, 2023, CNS Spectrums.

Health care resource use and cost differences by opioid therapy type among chronic noncancer pain patients

Nathaniel Katz, Richard White, K. Gajria, 2017, Journal of pain research.

Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study

R. Lipton, E. Aycardi, M. Bigal, 2021, Headache.

Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.

M. Fava, G. Sachs, P. Yeung, 2023, The American journal of psychiatry.

QUETIAPINE MAY REDUCE HOSTILITY IN PATIENTS WITH PSYCHOSES RELATED TO ALZHEIMER's DISEASE

L. Schneider, P. Yeung, D. Sweitzer, 1999 .